Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04169074
Title Modulation of the Tumor Microenvironment by Abemaciclib in Operable HPV-Negative Head and Neck Cancer (HNC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arizona
Indications

larynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

oropharynx cancer

Therapies

Abemaciclib

Abemaciclib + Nivolumab

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.